Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Production & Manufacturing
Return to: PBR Home | Production & Manufacturing
Today in Production & Manufacturing

Production & Manufacturing

Pfizer acquires InnoPharma Pfizer has completed the acquisition of US-based pharmaceutical development company InnoPharma, following receipt of US regulatory approval from all government authorities required by the agreement and other closing conditions. Production & Manufacturing > Manufacturing > News

Latest Production & Manufacturing News by Sector

Select a sector from the list or browse by sector below:

Fine & Speciality Chemicals

Bayer plans to focus entirely on Life Science businesses
Bayer intends in the future to focus entirely on the Life Science businesses – HealthCare and CropScience – and float MaterialScience on the stock market as a separate company. In this way Bayer is positioning itself as a world-leading company in the field of human, animal and plant health.
News
CordenPharma agrees to purchase Peptisyntha from Solvay
By PBR Staff Writer
International Chemical Investors Group (ICIG) and the Solvay Group have embarked on an agreement, whereby ICIG will purchase Belgium-based Peptisyntha SA, a custom manufacturer of peptides for pharmaceutical use.
News

Process & Production

FDA clears Tonix's IND for TNX-201 to treat episodic tension-type headache
By PBR Staff Writer
The US Food and Drug Administration (FDA) has cleared Tonix Pharmaceuticals' investigational new drug (IND) application to evaluate TNX-201, a single isomer of isometheptene (IMH), to treat episodic tension-type headache.
News
TWi Biotechnology's AC-201 secures FDA orphan drug status for epidermolysis bullosa
By PBR Staff Writer
TWi Biotechnology has received the Orphan Drug designation from the US food and Drug Administration (FDA) for AC-201, a first-in-class, small molecule, to treat epidermolysis bullosa (EB).
News

OTC

CHPA statement on pediatrics study reporting medication errors in children
The Consumer Healthcare Products Association (CHPA) issued the following statement in response to a study published today in Pediatrics. The study found that from 2002 to 2012 cough and cold medication errors decreased significantly in children under 6 years old, but the number of other medication errors rose to an average of 63,358 per year.
News
Therapix Biosciences signs non-binding agreement to acquire Dekel Pharmaceuticals
Therapix Bio announces that it recently entered into a Term Sheet for the acquisition of Dekel Pharmaceuticals, a privately-held company engaged in the research and development of drug therapies based on synthetic cannabinoid substances.
News

Manufacturing

FDA approves more manufacturing facilities for Halozyme's Hylenex recombinant production
By PBR Staff Writer
Halozyme Therapeutics has received approval from the US Food and Drug Administration (FDA) for new contract manufacturing facilities used in the production of Hylenex recombinant (hyaluronidase human injection).
News
Baxter introduces Hyqvia in US to treat primary immunodeficiency
By PBR Staff Writer
Baxter International and Halozyme Therapeutics have launched Hyqvia as a subcutaneous immunoglobulin treatment for adult patients with primary immunodeficiency (PI) in the US.
News